Johnson and Johnson | Lung Cancer Nursing UK Skip to main content

đź“… 20th - 21st June 2024 đź“Ť Glasgow

Johnson and Johnson

Platinum Sponsor
Janssen, the Pharmaceutical Companies of Johnson & Johnson, is evolving to become Johnson & Johnson Innovative Medicine. The Company is updating its brand and uniting both its pharmaceutical and MedTech segments under the Johnson & Johnson brand name.

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
The conference has been instigated and organised by LCNUK. Sponsors have contributed funding towards this event in return for exhibition space. They have had no input into the agenda or the selection of speakers with the exception of any sponsored symposia which are clearly indicated.

Join Lung Cancer Nursing UK

Be a member of a dynamic and cohesive forum of lung cancer nurse specialists (LCNS) working throughout the UK. Membership costs just ÂŁ30 per year and is open to any specialist nurse who spends more than 50% of their working week or clinical activities in caring for patients with lung cancer.

Join Now

Annual Conference

Join us for the LCNUK Conference 2024, the go-to event for any nurse working in lung cancer.

Held Thursday 20th - Friday 21st June at the Hilton Hotel, Glasgow. In this year’s event we’ll be returning to the fundamentals that are so important to our role focusing on patient centred care and symptom management.

Find out more